I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 35 studies | 49% ± 22% | |
| astrocyte | 20 studies | 71% ± 20% | |
| plasmacytoid dendritic cell | 19 studies | 38% ± 10% | |
| endothelial cell | 16 studies | 39% ± 20% | |
| oligodendrocyte | 15 studies | 74% ± 14% | |
| natural killer cell | 12 studies | 22% ± 5% | |
| connective tissue cell | 10 studies | 51% ± 20% | |
| oligodendrocyte precursor cell | 10 studies | 36% ± 18% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 22% ± 5% | |
| smooth muscle cell | 7 studies | 50% ± 22% | |
| pericyte | 6 studies | 36% ± 11% | |
| microglial cell | 6 studies | 50% ± 23% | |
| vein endothelial cell | 5 studies | 47% ± 18% | |
| retinal pigment epithelial cell | 5 studies | 75% ± 20% | |
| adventitial cell | 5 studies | 31% ± 12% | |
| Mueller cell | 5 studies | 83% ± 17% | |
| macrophage | 4 studies | 34% ± 13% | |
| podocyte | 4 studies | 62% ± 30% | |
| retinal ganglion cell | 4 studies | 31% ± 7% | |
| endothelial cell of artery | 4 studies | 25% ± 7% | |
| GABAergic neuron | 3 studies | 28% ± 13% | |
| glutamatergic neuron | 3 studies | 33% ± 16% | |
| glycinergic amacrine cell | 3 studies | 31% ± 4% | |
| myofibroblast cell | 3 studies | 47% ± 33% | |
| amacrine cell | 3 studies | 36% ± 12% | |
| cardiac muscle cell | 3 studies | 19% ± 4% | |
| epithelial cell | 3 studies | 25% ± 7% |
